BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29927498)

  • 1. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits.
    Ohtsuki M; Morimoto H; Nakagawa H
    J Dermatol; 2018 Aug; 45(8):936-942. PubMed ID: 29927498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
    Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
    BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience.
    Calzavara-Pinton P; Fabbrocini G; Girolomoni G; Matiucci A; Micali G; Musumeci ML; Patruno C; Pellacani G; Rossi MT; Castello M; Stingeni L
    G Ital Dermatol Venereol; 2020 Feb; 155(1):8-13. PubMed ID: 31760730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review.
    Zhao S; Hwang A; Miller C; Lio P
    Br J Clin Pharmacol; 2023 Jul; 89(7):2039-2065. PubMed ID: 37075252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.
    McCollum AD; Paik A; Eichenfield LF
    Pediatr Dermatol; 2010; 27(5):425-36. PubMed ID: 20678096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.
    Rustin MH
    Br J Dermatol; 2007 Nov; 157(5):861-73. PubMed ID: 17854353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical [symbol: see text] tacrolimus--a role in atopic dermatitis?
    Drug Ther Bull; 2002 Oct; 40(10):73-5. PubMed ID: 12434738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety of tacrolimus ointment in atopic dermatitis.
    Remitz A; Reitamo S
    Expert Opin Drug Saf; 2009 Jul; 8(4):501-6. PubMed ID: 19435404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.
    Luger T; Boguniewicz M; Carr W; Cork M; Deleuran M; Eichenfield L; Eigenmann P; Fölster-Holst R; Gelmetti C; Gollnick H; Hamelmann E; Hebert AA; Muraro A; Oranje AP; Paller AS; Paul C; Puig L; Ring J; Siegfried E; Spergel JM; Stingl G; Taieb A; Torrelo A; Werfel T; Wahn U
    Pediatr Allergy Immunol; 2015 Jun; 26(4):306-15. PubMed ID: 25557211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
    Draelos ZD
    Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
    Fleischer AB; Boguniewicz M
    J Drugs Dermatol; 2010 May; 9(5):488-98. PubMed ID: 20480792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.
    Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR
    J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
    Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
    Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus.
    Luger T; Augustin M; Lambert J; Paul C; Pincelli C; Torrelo A; Vestergaard C; Wahn U; Werfel T
    Pediatr Allergy Immunol; 2021 Apr; 32(3):414-424. PubMed ID: 33251600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.